Impact and cost-effectiveness of rotavirus vaccination in Bangladesh

by Clint Pecenka, Umesh Parashar, Jacqueline E. Tate et al.
Vaccine xxx (2017) xxx–xxx

6 pp. 681 kB
http://ac.els-cdn.com/S0264410X17307570/1-s2.0-S0264410X17307570-main.pdf?
_tid=d22ab004-53fd-11e7-a282-
00000aacb35f&acdnat=1497773707_7d57aab127293def4908aa3380f44b7b

Diarrheal disease is a leading cause of child mortality globally, and rotavirus is responsible for more than a third of those deaths. Despite substantial decreases, the number of rotavirus deaths in children under five was 215,000 per year in 2013. Of these deaths, approximately 41% occurred in Asia and 3% of those in Bangladesh. While Bangladesh has yet to introduce rotavirus vaccination, the country applied for Gavi support and plans to introduce it in 2018. This analysis evaluates the impact and cost-effectiveness of rotavirus vaccination in Bangladesh and provides estimates of the costs of the vaccination program to help inform decision-makers and international partners.

(Visited 18 times, 1 visits today)
This entry was posted in Essential Medicines, General, Maternal & Child Health, Other Infectious Diseases. Bookmark the permalink.